Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹65.23
1.75 (2.76%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹141 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹38.33+70.2%
52W High₹104-37.3%
Current Price
₹65.23
Circuit Limits (10%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹58.71
Upper Circuit₹71.75
Reference Price
₹65.23
Investment Checklist
Double Top on 1D (BREAKOUT CONFIRMED) — target ₹62.6
Double Top on 1D (BREAKOUT CONFIRMED) — target ₹57.55
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
47%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
63.49
EMA50
60.78
EMA200
65.04
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows6
Lower Highs4
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹65.47
₹67.26
₹68.79
₹69.93
₹71.25
Support (Below)
₹63.88
₹62.85
₹61.96
₹57.40
₹54.16
Volume Analysis
TrendSTABLE
Change-3.60%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹64.58
3% Risk₹63.27
5% Risk₹61.97
7% Risk (Custom)
₹60.66Technical Levels
1x ATR (Volatility)₹61.57
2x ATR (Swing)₹57.91
3x ATR (Trend)₹54.25
Immediate Support₹63.88
Moving Averages
EMA 9 (Short-term)₹64.96
EMA 20 (Medium-term)₹63.49
EMA 50 (Trend)₹60.78
EMA 200 (Long-term)₹65.04
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹6.1 Cr | ₹5.5 Cr | ₹4.2 Cr | ₹7.3 Cr |
| Net Profit | ₹-8.3 Cr | ₹-5.3 Cr | ₹-6.1 Cr | ₹-3.1 Cr |
| EPS | — | ₹-2.47 | ₹-2.85 | ₹-1.45 |
| Operating Profit | ₹-5.1 Cr | ₹-2.1 Cr | ₹-2.8 Cr | ₹30,10,000 |
ROE
18.42%
ROCE
-31.85%
Debt/Equity
-1.45
Current Ratio
0.10
OPM
4.14%
NPM
-42.98%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 20 Sept 2023 | Annual General Meeting | AGM |
| 15 Sept 2021 | Annual General Meeting | AGM |
| 16 Sept 2020 | Annual General Meeting | AGM |
| 13 Sept 2019 | Annual General Meeting | AGM |
| 31 Jan 2019 | Rights 21:100 @ Premium Rs 76 Per Share | RIGHTS_ISSUE |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for KREBSBIO
View AllNEWS
negative
Business Standard - Markets 23d ago
Krebs Biochemicals & Industries reports standalone net loss of Rs 2.34 crore in the March 2026 quarter
Sales rise 11.64% to Rs 6.81 crore
KREBSBIOHealthcare